NCT04751890

Brief Summary

A recent position paper calls for effective home-based exercise program for patients with peripheral artery disease (PAD) and claudication to be implemented in real-world care. This randomized-controlled trial aims to test the effects on mobility, hemodynamics and cardiovascular outcomes of a structured home-based exercise program (SHB) compared to walking advice (WA) recommendation intended as usual care, in PAD patients. Male and females PAD patients at Leriche-Fontaine's stage II and aged more than 60 years old will be enrolled. Patients will be randomized in SHB or WA groups. Patients of SHB group will receive a prescription of a home-based walking program during serial testing sessions at the hospital. The program will include two 10-minute sessions/day (6 days/week) of intermittent walking (1-minute work and 1-minute rest while seated) at a prescribed speed converted into a walking cadence and followed at home using a metronome. Two follow-up visits (at weeks 8 and 16) will be performed to evaluate patient adherence and to update the exercise program by increasing the walking speed. Patients randomized in WA group will receive the advice to walk as suggested by the guidelines. In particular, patients will be recommended to gather almost 30 minutes of walking at least 3 times per week; when they will face claudication pain, they will be allowed to rest and restart walking as soon as possible. Outcome measures will be performed at the entry prior to randomization, at the end of exercise programs (6-month) and after 12-month follow up. Primary outcomes will be the pain-free walking distance and the 6-minute walking distance collected during the 6-minute walking test Secondary outcomes will include ankle-brachial index, quality of life, lower limb strength and long-term clinical outcomes including revascularization and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 12, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 11, 2025

Status Verified

May 1, 2025

Enrollment Period

2.8 years

First QC Date

February 9, 2021

Last Update Submit

August 5, 2025

Conditions

Keywords

exerciserehabilitationexercise testing

Outcome Measures

Primary Outcomes (1)

  • 6-Minute Walking Test (mobility)

    Subjects will be instructed to walk as far as possible on a 21m walkway in 6 minutes, with their habitual walking device, with the possibility to slow down and rest if necessary. The total distance walked, the pain-free walking distance, and the perceived exertion at the end of the test will be recorded.

    Change at 6-month (end of training) respect to baseline

Secondary Outcomes (6)

  • Ankle Brachial Index (hemodynamics)

    Change at 6-month (end of training) respect to baseline

  • Vascu-QoL-6 (health-related quality of life)

    Change at 6-month (end of training) respect to baseline

  • 5-time sit-to-stand test (lower limbs strength)

    Change at 6-month (end of training) respect to baseline

  • Foot temperature

    Change at 6-month (end of training) respect to baseline

  • Number and rate of hospitalizations

    6-month, 12-month and 24-month (follow up)

  • +1 more secondary outcomes

Study Arms (2)

Structured home-based exercise

EXPERIMENTAL

Program will include two 8-minute sessions/day (6 days/week) of intermittent walking (1-minute work and 1-minute rest while seated) at a prescribed speed converted into a walking cadence and followed at home using a metronome. The walking sessions will be preferably performed indoors at home or on a treadmill. During the study, 2 follow-up visits (at weeks 8 and 16) will be performed to evaluate patient adherence to the program and to update the exercise program with the duration of each session that remained constant. The walking intensity of each exercise regime will be progressively modified to increase the training load. The patients will be asked to fill out a daily training record indicating completion of the exercise and any associated symptoms. Patients will have the ability to contact the rehabilitation team, composed of a physician and a sports science expert, throughout the entire study period via phone.

Behavioral: Structured home-based exercise

Walking advice

ACTIVE COMPARATOR

Patients will receive advice to walk as suggested by the guidelines. In particular, a team member will recommend patients to gather almost 30 minutes of walking at least 3 times per week; when the patient will face claudication pain, he/she will be allowed to rest, and restart walking as soon as possible. A daily log to be compiled will be provided to each patients to record the amount of walk performed.

Behavioral: Walking advice

Interventions

Low-intensity interval walking program prescribed at hospital and performed at daily at home

Structured home-based exercise
Walking adviceBEHAVIORAL

Walking advice according to the guidelines for peripheral artery disease patients

Walking advice

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male and females aged \> 60 years old
  • peripheral artery disease at Leriche-Fontaine's stage 2a or 2b
  • cognitive functioning to give informed consent identified by a Mini Mental Status Examination score ≥18/30.

You may not qualify if:

  • peripheral artery disease at Leriche-Fontaine's stage 1
  • peripheral artery disease at Leriche-Fontaine's stage 3 or more
  • severe cardio-respiratory conditions (e.g. unstable angina; severe heart failure identified by New York Heart Association class III or IV)
  • neurological or musculoskeletal conditions (e.g. above knee amputation) contraindicating or inhibiting exercise training.
  • very good exercise capacity determined by a 6-minute walking distance \> 500 meters.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Ferrara

Ferrara, 44124, Italy

Location

Related Publications (3)

  • Manfredini F, Malagoni AM, Mascoli F, Mandini S, Taddia MC, Basaglia N, Manfredini R, Conconi F, Zamboni P. Training rather than walking: the test in -train out program for home-based rehabilitation in peripheral arteriopathy. Circ J. 2008 Jun;72(6):946-52. doi: 10.1253/circj.72.946.

    PMID: 18503221BACKGROUND
  • Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, Rich K; American Heart Association Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019 Jan 22;139(4):e10-e33. doi: 10.1161/CIR.0000000000000623. No abstract available.

    PMID: 30586765BACKGROUND
  • Manfredini F, Lamberti N, Traina L, Zenunaj G, Medini C, Piva G, Straudi S, Manfredini R, Gasbarro V. Effectiveness of Home-Based Pain-Free Exercise versus Walking Advice in Patients with Peripheral Artery Disease: A Randomized Controlled Trial. Methods Protoc. 2021 May 10;4(2):29. doi: 10.3390/mps4020029.

MeSH Terms

Conditions

Peripheral Arterial DiseaseMotor Activity

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesBehavior

Study Officials

  • Fabio Manfredini, MD, PhD

    University of Ferrara and University Hospital of Ferrara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to patients' allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 12, 2021

Study Start

March 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

August 11, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results published at the end of the trial after deidentification.

Time Frame
Individual participant data will be available beginning 6 months following study results publication.
Access Criteria
Anyone who wishes to access the data.

Locations